Search Result "Glucagon-Like Peptide One Receptor Agonist (GLP-1 RA)"
Glucagon and Glucagon-Like Peptide Receptors as Drug Targets
Journal: Current Pharmaceutical Design
Volume: 12 Issue: 1 Year: 2006 Page: 1731-1750
Author(s): J. L. Estall, D. J. Drucker
Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in the Treatment of Obese Women with Polycystic Ovary Syndrome
Journal: Current Vascular Pharmacology
Volume: 15 Issue: 3 Year: 2017 Page: 218-229
Author(s): Themistoklis Tzotzas,Spyridon N. Karras,Niki Katsiki
The Discovery and Development of Glucagon-Like Peptide-1Receptor Agonists
Journal: Current Medicinal Chemistry
Volume: 31 Issue: 20 Year: 2024 Page: 2921-2943
Author(s):
Treatment of Type 1 Diabetic Patients with Glucagon-Like Peptide-1 (GLP-1) and GLP-1R Agonists
Journal: Current Diabetes Reviews
Volume: 5 Issue: 4 Year: 2009 Page: 266-275
Author(s): Urd Kielgast, Jens J. Holst, Sten Madsbad
Glucagon-like Peptide-1 Receptor Agonists Cardio-protective Effects: An Umbrella Review
Journal: Current Diabetes Reviews
Volume: 16 Issue: 8 Year: 2020 Page: 820-832
Author(s): Asim Ahmed Elnour,Noora Al Hajri,Israa Yousif El Khidir,Abdulla AlAmoodi,Sahar Asim Ahmed,Adel Sadeq
Pleiotropic Effects of Glucagon-like Peptide-1 (GLP-1)-Based Therapies on Vascular Complications in Diabetes
Journal: Current Pharmaceutical Design
Volume: 17 Issue: 3 Year: 2011 Page: 4379-4385
Author(s): Sho-ichi Yamagishi, Takanori Matsui
Glucagon-Like Peptide-1 Receptor Agonists for Type 2 Diabetes: A Clinical Update of Safety and Efficacy
Journal: Current Diabetes Reviews
Volume: 12 Issue: 4 Year: 2016 Page: 403-413
Author(s): Scott R. Drab
GLP-1/GLP-1RAs: New Options for the Drug Treatment of NAFLD
Journal: Current Pharmaceutical Design
Volume: 30 Issue: 2 Year: 2024 Page: 100-114
Author(s):
Impact of GLP-1 and GLP-1 Receptor Agonists on Cardiovascular Risk Factors in Type 2 Diabetes
Journal: Current Diabetes Reviews
Volume: 6 Issue: 4 Year: 2010 Page: 191-200
Author(s): Danilo Verge, Ximena Lopez
GLP-1 Receptor Agonists and Type 1 Diabetes - Where Do We Stand?
Journal: Current Pharmaceutical Design
Volume: 21 Issue: 36 Year: 2015 Page: 5292-5298
Author(s): Djordje S. Popovic,Edita Stokic,Stevan L. Popovic